Cargando…
Counterpoint: Intensive Glucose Control and Mortality in ACCORD—Still Looking for Clues
Autor principal: | Riddle, Matthew C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992221/ https://www.ncbi.nlm.nih.gov/pubmed/21115778 http://dx.doi.org/10.2337/dc10-1658 |
Ejemplares similares
-
Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target
por: Davidson, Mayer B.
Publicado: (2010) -
Counterpoint: Clinical Islet Transplantation: Not Ready for Prime Time
por: Khan, Mahfuzul H., et al.
Publicado: (2009) -
COUNTERPOINT: Tracheostomy in Patients With COVID-19: Should We Do It Before 14 Days? No
por: Pandian, Vinciya, et al.
Publicado: (2021) -
Point: Intensive Glycemic Control and Mortality in ACCORD—A Chance Finding?
por: Lachin, John M.
Publicado: (2010) -
COUNTERPOINT: Should Fellowship Interviews Remain Exclusively Virtual? No
por: Allam, J. Shirine
Publicado: (2021)